RNA-seq is a powerful tool for comprehensive characterization of whole transcriptome at both gene and exon levels and with a unique ability of identifying novel splicing variants. To date, RNA-seq analysis of HBV-related hepatocellular carcinoma (HCC) has not been reported. In this study, we performed transcriptome analyses for 10 matched pairs of cancer and non-cancerous tissues from HCC patients on Solexa/IUumina GAII platform. On average, about 21.6 million sequencing reads and 10.6 million aligned reads were obtained for samples sequenced on each lane, which was able to identify > 50％ of all the annotated genes for each sample. Furthermore, we identified 1,378 significantly differently expressed genes (DEGs) and 24, 338 differentially expressed exons (DEEs). Comprehensive function analyses indicated that cell growth-related, metabolismrelated and immune-related pathways were most significantly enriched by DEGs, pointing to a complex mechanism for HCC carcinogenesis. Positional gene enrichment analysis showed that DEGs were most significantly enriched at chromosome 8q21.3-24.3. The most interesting findings were from the analysis at exon levels where we characterized three major patterns of expression changes between gene and exon levels, implying a much complex landscape of transcript-specific differential expressions in HCC. Finally, we identified a novel highly up-regulated exon-exon junction in ATAD2 gene in HCC tissues. Overall, to our best knowledge, our study represents the most comprehensive characterization of HBVrelated HCC transcriptome including exon level expression changes and novel splicing variants, which illustrated the power of RNA-seq and provided important clues for understanding the molecular mechanisms of HCC pathogenesis at system-wide levels.
Qichao Huang Dong Wu Feng Shen Jinliang Xing Zhi-Nan Chen Biaoyang Lin Hanqiang Liu Xi Ma Fan Mo Wei Yu Lisha Li Hongwei Li Turn Turn
State Key Laboratory of Cancer Biology, Cell Engineering Research Center & Department of Cell Biolog Department of Comprehensive Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medic Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang Un Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang Un Institute of Life Science and Biotechnology, Beijing Jiaotong University, Beijing, 100044, P. R.Chin
(0)